Apex Biotechnology Corp. (TPE:1733)

Apex Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	532.69	382.05	331.71	555.33	786.95
Trading Asset Securities	66.1	61.87	65.83	69.72	36.01
Cash & Short-Term Investments	598.78	443.91	397.53	625.05	822.96
Cash Growth	34.89%	11.67%	-36.40%	-24.05%	2.48%
Accounts Receivable	346.64	288.39	486.77	474.41	325.41
Other Receivables	8.08	5.72	10.12	13.97	17.28
Receivables	354.72	294.11	496.89	488.38	342.68
Inventory	662.49	747.71	739.25	628.59	504.54
Prepaid Expenses	24.78	18.51	19	11.06	13.47
Other Current Assets	2.29	2.4	1.81	6.78	0.83
Total Current Assets	1,643	1,507	1,654	1,760	1,684
Property, Plant & Equipment	695.81	720.59	766.08	794.12	827.81
Other Intangible Assets	39.6	44.22	69.14	106.48	128.92
Long-Term Deferred Tax Assets	9.24	4.24	3.62	0.43	2.39
Other Long-Term Assets	32.23	21.32	21.38	9.58	7.86
Total Assets	2,420	2,297	2,515	2,670	2,651
Accounts Payable	239.03	156.22	289.69	343.89	245
Accrued Expenses	142.25	133.43	150.55	148.07	125.41
Short-Term Debt	-	30	50	150	-
Current Portion of Long-Term Debt	-	-	-	-	389.88
Current Portion of Leases	9.03	7.2	8.01	6.88	5.56
Current Income Taxes Payable	24.52	46.24	36.92	40.12	70.28
Current Unearned Revenue	58.28	6.6	29.04	93.06	42.61
Other Current Liabilities	4.68	3.67	6.35	3.87	4.7
Total Current Liabilities	477.78	383.35	570.55	785.89	883.43
Long-Term Leases	113.93	116.2	122.67	127.66	118.28
Long-Term Deferred Tax Liabilities	3.54	0.04	3.1	2.88	1.21
Other Long-Term Liabilities	0.47	0.48	0.49	0.48	0.48
Total Liabilities	595.7	500.07	696.81	916.91	1,005
Common Stock	999.5	999.5	999.5	999.5	999.5
Additional Paid-In Capital	68.37	68.37	68.37	68.37	66.78
Retained Earnings	744.06	718.87	739.95	682.34	586.9
Treasury Stock	-	-	-	-	-12.25
Comprehensive Income & Other	11.67	9.69	9.51	2.52	4.45
Total Common Equity	1,824	1,796	1,817	1,753	1,645
Minority Interest	0.63	0.5	0.57	0.82	0.78
Shareholders' Equity	1,824	1,797	1,818	1,754	1,646
Total Liabilities & Equity	2,420	2,297	2,515	2,670	2,651
Total Debt	122.96	153.4	180.68	284.55	513.72
Net Cash (Debt)	475.83	290.52	216.85	340.5	309.24
Net Cash Growth	63.79%	33.97%	-36.31%	10.11%	61.63%
Net Cash Per Share	4.74	2.90	2.15	3.22	2.74
Filing Date Shares Outstanding	99.95	99.95	99.95	99.95	99.38
Total Common Shares Outstanding	99.95	99.95	99.95	99.95	99.38
Working Capital	1,165	1,123	1,084	973.97	801.05
Book Value Per Share	18.25	17.97	18.18	17.54	16.56
Tangible Book Value	1,784	1,752	1,748	1,646	1,516
Tangible Book Value Per Share	17.85	17.53	17.49	16.47	15.26
Land	261.68	261.68	261.68	261.68	261.68
Buildings	605.02	604.13	604.13	601.96	601.58
Machinery	806.49	789.71	777.35	754.25	748.98
Leasehold Improvements	-	-	-	-	0.43

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.